Načítá se...
CXCR2: a target for pancreatic cancer treatment?
INTRODUCTION: Pancreatic cancer, a leading cause of cancer deaths worldwide, is very aggressive and has minimally effective treatment options. For those who have no surgical options, medical treatments are limited. The chemokine receptor CXCR2 has become the subject of much interest recently because...
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2013
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3686651/ https://ncbi.nlm.nih.gov/pubmed/23425074 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/14728222.2013.772137 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|